Prediction tool for choosing treatment in sarcoma care
Part of Cancer clinical trials.
This trial tests a way to use patient information to help doctors decide which treatment approach may fit best for people with certain bone or soft-tissue tumors. It may help improve selection and care planning, but it depends on whether your data can be used.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a cancerous or specific borderline/selected non-cancer bone or soft-tissue tumor
- Your tumor type matches the Swiss Sarcoma Network’s listed categories
- You are allowed to be any age
- You are female or male
- You do not object to the later use of your personal health data
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a health registry that collects information about people with soft-tissue or bone sarcoma. It helps researchers understand how the disease behaves and what outcomes different treatments lead to.
This trial tests a precision medicine approach by giving targeted therapy before surgery for high-risk soft tissue sarcoma. The goal is to see if matching treatment to your tumor's type can improve outcomes.
This study is for people who have been diagnosed with bone or soft tissue sarcoma confirmed by a tissue test. It may help researchers understand sarcoma better, but you must be able to understand and consent to take part.
This study uses QPOP to predict which treatment may work best for people with sarcoma or melanoma. It mainly needs tumor samples from a new biopsy or surgery so researchers can run the test and compare results to treatment choices.
This trial builds a national database of people diagnosed with sarcoma in French cancer centers. It may help researchers better understand sarcoma types and care patterns, which can improve future treatment decisions.
This study looks at stored tumor tissue (or takes a new biopsy) to measure specific tumor markers. Researchers want to see whether these markers match how well chemotherapy works before surgery for soft-tissue sarcoma.
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.